Website intended for a NZ health professional readership
We are on our summer break and the editorial office is closed until 13 January. In the meantime, please enjoy our Summer Hiatus series, in which our journalists curate an eclectic mix from our news and clinical archives throughout the year, The Conversation and other publications we share content with. Please note the comment function has been turned off while we are away. Happy reading!
This article was first published online on 19 June.
This article looks at how to prescribe digital mental health interventions to young people, even if you are a ‘digital immigrant’
1. DaRocha M, Chinn V, Ormerod F, Fleming T. Aotearoa New Zealand Digital Tools for Mental Health and Wellbeing: Stocktake. Wellington, NZ: Health Promotion Agency; 2021.
2. Thabrew H, Boggiss AL, Lim D, et al. Well-being app to support young people during the COVID-19 pandemic: randomised controlled trial. BMJ Open 2022;12(5):e058144.
3. O’Daffer A, Colt SF, Wasil AR, Lau N. Efficacy and conflicts of interest in randomized controlled trials evaluating Headspace and Calm apps: Systematic review. JMIR Ment Health 2022;9(9):e40924.
4. Bennett S, Maton K, Kervin L. The ‘digital natives’ debate: A critical review of the evidence. British Journal of Educational Technology 39(5):775–86.
5. Thabrew H, Gega L. Editorial: Control alt delete – technology and children's mental health. Child Adolesc Ment Health 2023;28(1):1–3.
6. Chisolm DJ, Gardner W, Julian T, Kelleher KJ. Adolescent satisfaction with computer-assisted behavioural risk screening in primary care. Child Adolesc Ment Health 2008;13(4):163–68.
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
